Morgan Stanley began coverage on shares of Ardent Health Partners (NYSE:ARDT – Free Report) in a report released on Monday, MarketBeat reports. The brokerage issued an overweight rating and a $27.00 price target on the stock.
A number of other equities research analysts have also recently commented on ARDT. JPMorgan Chase & Co. began coverage on Ardent Health Partners in a report on Monday. They set a neutral rating and a $18.00 price target on the stock. SVB Leerink started coverage on shares of Ardent Health Partners in a report on Monday. They set an outperform rating and a $23.00 price objective for the company. Mizuho initiated coverage on shares of Ardent Health Partners in a research report on Monday. They set an outperform rating and a $20.00 target price for the company. Finally, Truist Financial started coverage on shares of Ardent Health Partners in a report on Monday. They issued a buy rating and a $21.00 price target on the stock. One analyst has rated the stock with a hold rating, nine have given a buy rating and one has assigned a strong buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of Buy and a consensus price target of $21.70.
View Our Latest Stock Analysis on Ardent Health Partners
Ardent Health Partners Trading Up 6.1 %
About Ardent Health Partners
We are the fourth largest privately held, for-profit operator of hospitals and a leading provider of healthcare services in the United States(1). We currently operate in eight growing mid-sized urban markets across six states: Texas, Oklahoma, New Mexico, New Jersey, Idaho, and Kansas. We deliver care through a system of 30 acute care hospitals, more than 200 sites of care, and over 1,700 providers that are either employed by or affiliated with us(2), as of March 31, 2024.
Further Reading
- Five stocks we like better than Ardent Health Partners
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- High Dividend REITs: Are They an Ideal Way to Diversify?
- Jeff Brown’s Exegesis AI Stock Picks
- Stock Splits, Do They Really Impact Investors?
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.